These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23825712)

  • 1. Intravitreal diclofenac for refractory uveitic cystoid macular edema.
    Ramezani A; Fard Esmaeilpour N; Eskandari A; Rabbanikhah Z; Soheilian R; Soheilian M
    J Ophthalmic Vis Res; 2013 Jan; 8(1):47-52. PubMed ID: 23825712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
    Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Soheilian R
    Ocul Immunol Inflamm; 2013 Apr; 21(2):124-9. PubMed ID: 23697857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study.
    Kianersi F; Rezaeian-Ramsheh A; Pourazizi M; Kianersi H
    Acta Ophthalmol; 2018 May; 96(3):e355-e360. PubMed ID: 29369543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INTRAVITREAL DICLOFENAC VERSUS INTRAVITREAL TRIAMCINOLONE FOR THE TREATMENT OF UVEITIC CYSTOID MACULAR EDEMA.
    Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Esmaeilpour NF; Soheilian R
    Retina; 2013 Apr; ():. PubMed ID: 23584700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.
    Lasave AF; Zeballos DG; El-Haig WM; Díaz-Llopis M; Salom D; Arevalo JF
    Ocul Immunol Inflamm; 2009; 17(6):423-30. PubMed ID: 20001264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies.
    Soheilian M; Karimi S; Ramezani A; Peyman GA
    Retina; 2010 Mar; 30(3):509-15. PubMed ID: 19952986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.
    Lasave AF; Schlaen A; Zeballos DG; Díaz-Llopis M; Couto C; El-Haig WM; Arevalo JF
    Ocul Immunol Inflamm; 2019; 27(2):294-302. PubMed ID: 29157128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema.
    Bansal P; Agarwal A; Gupta V; Singh R; Gupta A
    Indian J Ophthalmol; 2015 May; 63(5):416-22. PubMed ID: 26139803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
    Rahimi M; Shahrzad SS; Banifatemi M
    Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab versus triamcinolone acetonide for refractory uveitic cystoid macular edema: a randomized pilot study.
    Soheilian M; Rabbanikhah Z; Ramezani A; Kiavash V; Yaseri M; Peyman GA
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):199-206. PubMed ID: 20307215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results.
    Arevalo JF; Maia M; Garcia-Amaris RA; Roca JA; Sanchez JG; Berrocal MH; Wu L;
    Ophthalmology; 2009 Aug; 116(8):1481-7, 1487.e1. PubMed ID: 19545901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.
    Cervantes-Castañeda RA; Giuliari GP; Gallagher MJ; Yilmaz T; MacDonell RE; Quinones K; Foster CS
    Eur J Ophthalmol; 2009; 19(4):622-9. PubMed ID: 19551679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.
    Habot-Wilner Z; Sallam A; Pacheco PA; Do HH; McCluskey P; Lightman S
    Eur J Ophthalmol; 2011; 21 Suppl 6():S56-61. PubMed ID: 23264330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical dorzolamide 2% in diabetic cystoid macular edema.
    Badawi AE; Mokbel TH; Elhefney EM; Hagras SM; Abdelhameed AG
    Int J Ophthalmol; 2021; 14(9):1413-1418. PubMed ID: 34540619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
    Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
    Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome.
    Demirel S; Batioğlu F; Özmert E
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):636-9. PubMed ID: 22731243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
    Russo V; Barone A; Conte E; Prascina F; Stella A; Noci ND
    Retina; 2009 Apr; 29(4):511-5. PubMed ID: 19174717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.